Vilà MR - Search Results

1

HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.

Cuadros T, Trilla E, Sarró E, Vilà MR, Vilardell J, de Torres I, Salcedo M, López-Hellin J, Sánchez A, Ramón y Cajal S, Itarte E, Morote J, Meseguer A. Cuadros T, et al. Among authors: vila mr. Cancer Res. 2014 Mar 1;74(5):1416-28. doi: 10.1158/0008-5472.CAN-13-1671. Epub 2014 Jan 3. Cancer Res. 2014. PMID: 24390735

2

Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction.

Vilà MR, Nicolás A, Morote J, de I, Meseguer A. Vilà MR, et al. Cancer. 2000 Jul 1;89(1):152-64. Cancer. 2000. PMID: 10897012

3

Hepatitis A virus receptor blocks cell differentiation and is overexpressed in clear cell renal cell carcinoma.

Vilà MR, Kaplan GG, Feigelstock D, Nadal M, Morote J, Porta R, Bellmunt J, Meseguer A. Vilà MR, et al. Kidney Int. 2004 May;65(5):1761-73. doi: 10.1111/j.1523-1755.2004.00601.x. Kidney Int. 2004. PMID: 15086915 Free article.

4

Altered gene transcription profiles in fibroblasts harboring either TK2 or DGUOK mutations indicate compensatory mechanisms.

Villarroya J, de Bolós C, Meseguer A, Hirano M, Vilà MR. Villarroya J, et al. Among authors: vila mr. Exp Cell Res. 2009 May 1;315(8):1429-38. doi: 10.1016/j.yexcr.2009.02.018. Epub 2009 Mar 3. Exp Cell Res. 2009. PMID: 19265691 Free PMC article.

5

Higher processing rates of Alu-containing sequences in kidney tumors and cell lines with overexpressed Alu-mRNAs.

Vilà MR, Gelpí C, Nicolás A, Morote J, Schwartz S Jr, Schwartz S, Meseguer A. Vilà MR, et al. Oncol Rep. 2003 Nov-Dec;10(6):1903-9. Oncol Rep. 2003. PMID: 14534716

6

Transcriptomic and proteomic analysis of liver and muscle alterations caused by surgical stress in rats.

López-Hellín J, Gonzalo R, Tejeda M, Carrascal M, Vilà MR, Abián J, García-Arumí E. López-Hellín J, et al. Among authors: vila mr. Clin Sci (Lond). 2005 Feb;108(2):167-78. doi: 10.1042/CS20040144. Clin Sci (Lond). 2005. PMID: 15504105

7

Selective muscle fiber loss and molecular compensation in mitochondrial myopathy due to TK2 deficiency.

Vilà MR, Villarroya J, García-Arumí E, Castellote A, Meseguer A, Hirano M, Roig M. Vilà MR, et al. J Neurol Sci. 2008 Apr 15;267(1-2):137-41. doi: 10.1016/j.jns.2007.10.019. Epub 2007 Nov 19. J Neurol Sci. 2008. PMID: 18021809 Free PMC article.

8

Targeted impairment of thymidine kinase 2 expression in cells induces mitochondrial DNA depletion and reveals molecular mechanisms of compensation of mitochondrial respiratory activity.

Villarroya J, Lara MC, Dorado B, Garrido M, García-Arumí E, Meseguer A, Hirano M, Vilà MR. Villarroya J, et al. Among authors: vila mr. Biochem Biophys Res Commun. 2011 Apr 8;407(2):333-8. doi: 10.1016/j.bbrc.2011.03.018. Epub 2011 Mar 5. Biochem Biophys Res Commun. 2011. PMID: 21382338 Free PMC article.

9

A novel autosomal dominant limb-girdle muscular dystrophy (LGMD 1F) maps to 7q32.1-32.2.

Palenzuela L, Andreu AL, Gàmez J, Vilà MR, Kunimatsu T, Meseguer A, Cervera C, Fernandez Cadenas I, van der Ven PF, Nygaard TG, Bonilla E, Hirano M. Palenzuela L, et al. Among authors: vila mr. Neurology. 2003 Aug 12;61(3):404-6. doi: 10.1212/01.wnl.0000073984.46546.4f. Neurology. 2003. PMID: 12913210

10

Reversion of mtDNA depletion in a patient with TK2 deficiency.

Vilà MR, Segovia-Silvestre T, Gámez J, Marina A, Naini AB, Meseguer A, Lombès A, Bonilla E, DiMauro S, Hirano M, Andreu AL. Vilà MR, et al. Neurology. 2003 Apr 8;60(7):1203-5. doi: 10.1212/01.wnl.0000055928.58122.47. Neurology. 2003. PMID: 12682338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters